TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients

BACKGROUND: Angiogenesis appears to play an important role in ovarian cancer. Vascular endothelial growth factor (VEGF) has recently been implicated as a therapeutic target in ovarian cancer. The tissue inhibitor of metalloproteinase 1 (TIMP-1) is involved in tissue invasion and angiogenesis. The ap...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Mahner, Sven, Woelber, Linn, Eulenburg, Christine, Schwarz, Joerg, Carney, Walter, Jaenicke, Fritz, Milde-Langosch, Karin, Mueller, Volkmar
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2010
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2873384/
https://ncbi.nlm.nih.gov/pubmed/20388222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-139
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы